Search

Your search keyword '"Manyam, Ganiraju C"' showing total 378 results
Start Over Author "Manyam, Ganiraju C"
378 results on '"Manyam, Ganiraju C"'

2. Lentiviral interferon: A novel method for gene therapy in bladder cancer

Author

Mokkapati, Sharada, Narayan, Vikram M., Manyam, Ganiraju C., Lim, Amy H., Duplisea, Jonathan J., Kokorovic, Andrea, Miest, Tanner S., Mitra, Anirban P., Plote, Devin, Anand, Selvalakshmi Selvaraj, Metcalfe, Michael J., Dunner, Kenneth, Jr., Johnson, Burles A., Czerniak, Bogdan A., Nieminen, Tiina, Heikura, Tommi, Yla-Herttuala, Seppo, Parker, Nigel R., Schluns, Kimberley S., McConkey, David J., and Dinney, Colin P.

Published
2022
Full Text
View/download PDF

3. A phase II trial of apalutamide for intermediate‐risk prostate cancer and molecular correlates

Author

Hahn, Andrew W., primary, Manyam, Ganiraju C., additional, Chapin, Brian F., additional, Zhang, Miao, additional, Yu, Yao, additional, Pettaway, Curtis A., additional, Chery, Lisly, additional, Pisters, Louis L., additional, Ward, John F., additional, Gregg, Justin R., additional, Papadopoulos, John, additional, Kamat, Ashish M., additional, Lozano, Marisa, additional, Hoang, Anh, additional, Broom, Bradley, additional, Wang, Xuemei, additional, Huff, Chad D., additional, Logothetis, Christopher J., additional, Troncoso, Patricia, additional, Pilié, Patrick G., additional, and Davis, John W., additional

Published
2024
Full Text
View/download PDF

5. Supplementary Table 6 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, primary, Duose, Dzifa Yawa, primary, Gonzalez-Kozlova, Edgar, primary, Redman, Mary W., primary, Chen, Hong, primary, Manyam, Ganiraju C., primary, Kumar, Gayatri, primary, Zhang, Jianhua, primary, Song, Xingzhi, primary, Lazcano, Rossana, primary, Marques-Piubelli, Mario L., primary, Laberiano-Fernandez, Caddie, primary, Rojas, Frank, primary, Zhang, Baili, primary, Taing, Len, primary, Jhaveri, Aashna, primary, Geisberg, Jacob, primary, Altreuter, Jennifer, primary, Michor, Franziska, primary, Provencher, James, primary, Yu, Joyce, primary, Cerami, Ethan, primary, Moravec, Radim, primary, Kannan, Kasthuri, primary, Luthra, Rajyalakshmi, primary, Alatrash, Gheath, primary, Huang, Hsin-Hui, primary, Xie, Hui, primary, Patel, Manishkumar, primary, Nie, Kai, primary, Harris, Jocelyn, primary, Argueta, Kimberly, primary, Lindsay, James, primary, Biswas, Roshni, primary, Van Nostrand, Stephen, primary, Kim-Schulze, Seunghee, primary, Gray, Jhanelle E., primary, Herbst, Roy S., primary, Wistuba, Ignacio I., primary, Gettinger, Scott, primary, Kelly, Karen, primary, Bazhenova, Lyudmila, primary, Gnjatic, Sacha, primary, Lee, J. Jack, primary, Zhang, Jianjun, primary, and Haymaker, Cara, primary

Published
2024
Full Text
View/download PDF

6. Supplementary Figure 6 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, primary, Duose, Dzifa Yawa, primary, Gonzalez-Kozlova, Edgar, primary, Redman, Mary W., primary, Chen, Hong, primary, Manyam, Ganiraju C., primary, Kumar, Gayatri, primary, Zhang, Jianhua, primary, Song, Xingzhi, primary, Lazcano, Rossana, primary, Marques-Piubelli, Mario L., primary, Laberiano-Fernandez, Caddie, primary, Rojas, Frank, primary, Zhang, Baili, primary, Taing, Len, primary, Jhaveri, Aashna, primary, Geisberg, Jacob, primary, Altreuter, Jennifer, primary, Michor, Franziska, primary, Provencher, James, primary, Yu, Joyce, primary, Cerami, Ethan, primary, Moravec, Radim, primary, Kannan, Kasthuri, primary, Luthra, Rajyalakshmi, primary, Alatrash, Gheath, primary, Huang, Hsin-Hui, primary, Xie, Hui, primary, Patel, Manishkumar, primary, Nie, Kai, primary, Harris, Jocelyn, primary, Argueta, Kimberly, primary, Lindsay, James, primary, Biswas, Roshni, primary, Van Nostrand, Stephen, primary, Kim-Schulze, Seunghee, primary, Gray, Jhanelle E., primary, Herbst, Roy S., primary, Wistuba, Ignacio I., primary, Gettinger, Scott, primary, Kelly, Karen, primary, Bazhenova, Lyudmila, primary, Gnjatic, Sacha, primary, Lee, J. Jack, primary, Zhang, Jianjun, primary, and Haymaker, Cara, primary

Published
2024
Full Text
View/download PDF

7. Supplementary Figure 8 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, primary, Duose, Dzifa Yawa, primary, Gonzalez-Kozlova, Edgar, primary, Redman, Mary W., primary, Chen, Hong, primary, Manyam, Ganiraju C., primary, Kumar, Gayatri, primary, Zhang, Jianhua, primary, Song, Xingzhi, primary, Lazcano, Rossana, primary, Marques-Piubelli, Mario L., primary, Laberiano-Fernandez, Caddie, primary, Rojas, Frank, primary, Zhang, Baili, primary, Taing, Len, primary, Jhaveri, Aashna, primary, Geisberg, Jacob, primary, Altreuter, Jennifer, primary, Michor, Franziska, primary, Provencher, James, primary, Yu, Joyce, primary, Cerami, Ethan, primary, Moravec, Radim, primary, Kannan, Kasthuri, primary, Luthra, Rajyalakshmi, primary, Alatrash, Gheath, primary, Huang, Hsin-Hui, primary, Xie, Hui, primary, Patel, Manishkumar, primary, Nie, Kai, primary, Harris, Jocelyn, primary, Argueta, Kimberly, primary, Lindsay, James, primary, Biswas, Roshni, primary, Van Nostrand, Stephen, primary, Kim-Schulze, Seunghee, primary, Gray, Jhanelle E., primary, Herbst, Roy S., primary, Wistuba, Ignacio I., primary, Gettinger, Scott, primary, Kelly, Karen, primary, Bazhenova, Lyudmila, primary, Gnjatic, Sacha, primary, Lee, J. Jack, primary, Zhang, Jianjun, primary, and Haymaker, Cara, primary

Published
2024
Full Text
View/download PDF

8. Supplementary Table 3 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, primary, Duose, Dzifa Yawa, primary, Gonzalez-Kozlova, Edgar, primary, Redman, Mary W., primary, Chen, Hong, primary, Manyam, Ganiraju C., primary, Kumar, Gayatri, primary, Zhang, Jianhua, primary, Song, Xingzhi, primary, Lazcano, Rossana, primary, Marques-Piubelli, Mario L., primary, Laberiano-Fernandez, Caddie, primary, Rojas, Frank, primary, Zhang, Baili, primary, Taing, Len, primary, Jhaveri, Aashna, primary, Geisberg, Jacob, primary, Altreuter, Jennifer, primary, Michor, Franziska, primary, Provencher, James, primary, Yu, Joyce, primary, Cerami, Ethan, primary, Moravec, Radim, primary, Kannan, Kasthuri, primary, Luthra, Rajyalakshmi, primary, Alatrash, Gheath, primary, Huang, Hsin-Hui, primary, Xie, Hui, primary, Patel, Manishkumar, primary, Nie, Kai, primary, Harris, Jocelyn, primary, Argueta, Kimberly, primary, Lindsay, James, primary, Biswas, Roshni, primary, Van Nostrand, Stephen, primary, Kim-Schulze, Seunghee, primary, Gray, Jhanelle E., primary, Herbst, Roy S., primary, Wistuba, Ignacio I., primary, Gettinger, Scott, primary, Kelly, Karen, primary, Bazhenova, Lyudmila, primary, Gnjatic, Sacha, primary, Lee, J. Jack, primary, Zhang, Jianjun, primary, and Haymaker, Cara, primary

Published
2024
Full Text
View/download PDF

9. Supplementary Figure 1 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, primary, Duose, Dzifa Yawa, primary, Gonzalez-Kozlova, Edgar, primary, Redman, Mary W., primary, Chen, Hong, primary, Manyam, Ganiraju C., primary, Kumar, Gayatri, primary, Zhang, Jianhua, primary, Song, Xingzhi, primary, Lazcano, Rossana, primary, Marques-Piubelli, Mario L., primary, Laberiano-Fernandez, Caddie, primary, Rojas, Frank, primary, Zhang, Baili, primary, Taing, Len, primary, Jhaveri, Aashna, primary, Geisberg, Jacob, primary, Altreuter, Jennifer, primary, Michor, Franziska, primary, Provencher, James, primary, Yu, Joyce, primary, Cerami, Ethan, primary, Moravec, Radim, primary, Kannan, Kasthuri, primary, Luthra, Rajyalakshmi, primary, Alatrash, Gheath, primary, Huang, Hsin-Hui, primary, Xie, Hui, primary, Patel, Manishkumar, primary, Nie, Kai, primary, Harris, Jocelyn, primary, Argueta, Kimberly, primary, Lindsay, James, primary, Biswas, Roshni, primary, Van Nostrand, Stephen, primary, Kim-Schulze, Seunghee, primary, Gray, Jhanelle E., primary, Herbst, Roy S., primary, Wistuba, Ignacio I., primary, Gettinger, Scott, primary, Kelly, Karen, primary, Bazhenova, Lyudmila, primary, Gnjatic, Sacha, primary, Lee, J. Jack, primary, Zhang, Jianjun, primary, and Haymaker, Cara, primary

Published
2024
Full Text
View/download PDF

10. Supplementary Table 1 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, primary, Duose, Dzifa Yawa, primary, Gonzalez-Kozlova, Edgar, primary, Redman, Mary W., primary, Chen, Hong, primary, Manyam, Ganiraju C., primary, Kumar, Gayatri, primary, Zhang, Jianhua, primary, Song, Xingzhi, primary, Lazcano, Rossana, primary, Marques-Piubelli, Mario L., primary, Laberiano-Fernandez, Caddie, primary, Rojas, Frank, primary, Zhang, Baili, primary, Taing, Len, primary, Jhaveri, Aashna, primary, Geisberg, Jacob, primary, Altreuter, Jennifer, primary, Michor, Franziska, primary, Provencher, James, primary, Yu, Joyce, primary, Cerami, Ethan, primary, Moravec, Radim, primary, Kannan, Kasthuri, primary, Luthra, Rajyalakshmi, primary, Alatrash, Gheath, primary, Huang, Hsin-Hui, primary, Xie, Hui, primary, Patel, Manishkumar, primary, Nie, Kai, primary, Harris, Jocelyn, primary, Argueta, Kimberly, primary, Lindsay, James, primary, Biswas, Roshni, primary, Van Nostrand, Stephen, primary, Kim-Schulze, Seunghee, primary, Gray, Jhanelle E., primary, Herbst, Roy S., primary, Wistuba, Ignacio I., primary, Gettinger, Scott, primary, Kelly, Karen, primary, Bazhenova, Lyudmila, primary, Gnjatic, Sacha, primary, Lee, J. Jack, primary, Zhang, Jianjun, primary, and Haymaker, Cara, primary

Published
2024
Full Text
View/download PDF

11. Supplementary Figure 7 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, primary, Duose, Dzifa Yawa, primary, Gonzalez-Kozlova, Edgar, primary, Redman, Mary W., primary, Chen, Hong, primary, Manyam, Ganiraju C., primary, Kumar, Gayatri, primary, Zhang, Jianhua, primary, Song, Xingzhi, primary, Lazcano, Rossana, primary, Marques-Piubelli, Mario L., primary, Laberiano-Fernandez, Caddie, primary, Rojas, Frank, primary, Zhang, Baili, primary, Taing, Len, primary, Jhaveri, Aashna, primary, Geisberg, Jacob, primary, Altreuter, Jennifer, primary, Michor, Franziska, primary, Provencher, James, primary, Yu, Joyce, primary, Cerami, Ethan, primary, Moravec, Radim, primary, Kannan, Kasthuri, primary, Luthra, Rajyalakshmi, primary, Alatrash, Gheath, primary, Huang, Hsin-Hui, primary, Xie, Hui, primary, Patel, Manishkumar, primary, Nie, Kai, primary, Harris, Jocelyn, primary, Argueta, Kimberly, primary, Lindsay, James, primary, Biswas, Roshni, primary, Van Nostrand, Stephen, primary, Kim-Schulze, Seunghee, primary, Gray, Jhanelle E., primary, Herbst, Roy S., primary, Wistuba, Ignacio I., primary, Gettinger, Scott, primary, Kelly, Karen, primary, Bazhenova, Lyudmila, primary, Gnjatic, Sacha, primary, Lee, J. Jack, primary, Zhang, Jianjun, primary, and Haymaker, Cara, primary

Published
2024
Full Text
View/download PDF

12. Data from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, primary, Duose, Dzifa Yawa, primary, Gonzalez-Kozlova, Edgar, primary, Redman, Mary W., primary, Chen, Hong, primary, Manyam, Ganiraju C., primary, Kumar, Gayatri, primary, Zhang, Jianhua, primary, Song, Xingzhi, primary, Lazcano, Rossana, primary, Marques-Piubelli, Mario L., primary, Laberiano-Fernandez, Caddie, primary, Rojas, Frank, primary, Zhang, Baili, primary, Taing, Len, primary, Jhaveri, Aashna, primary, Geisberg, Jacob, primary, Altreuter, Jennifer, primary, Michor, Franziska, primary, Provencher, James, primary, Yu, Joyce, primary, Cerami, Ethan, primary, Moravec, Radim, primary, Kannan, Kasthuri, primary, Luthra, Rajyalakshmi, primary, Alatrash, Gheath, primary, Huang, Hsin-Hui, primary, Xie, Hui, primary, Patel, Manishkumar, primary, Nie, Kai, primary, Harris, Jocelyn, primary, Argueta, Kimberly, primary, Lindsay, James, primary, Biswas, Roshni, primary, Van Nostrand, Stephen, primary, Kim-Schulze, Seunghee, primary, Gray, Jhanelle E., primary, Herbst, Roy S., primary, Wistuba, Ignacio I., primary, Gettinger, Scott, primary, Kelly, Karen, primary, Bazhenova, Lyudmila, primary, Gnjatic, Sacha, primary, Lee, J. Jack, primary, Zhang, Jianjun, primary, and Haymaker, Cara, primary

Published
2024
Full Text
View/download PDF

13. Supplementary Figure 2 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, primary, Duose, Dzifa Yawa, primary, Gonzalez-Kozlova, Edgar, primary, Redman, Mary W., primary, Chen, Hong, primary, Manyam, Ganiraju C., primary, Kumar, Gayatri, primary, Zhang, Jianhua, primary, Song, Xingzhi, primary, Lazcano, Rossana, primary, Marques-Piubelli, Mario L., primary, Laberiano-Fernandez, Caddie, primary, Rojas, Frank, primary, Zhang, Baili, primary, Taing, Len, primary, Jhaveri, Aashna, primary, Geisberg, Jacob, primary, Altreuter, Jennifer, primary, Michor, Franziska, primary, Provencher, James, primary, Yu, Joyce, primary, Cerami, Ethan, primary, Moravec, Radim, primary, Kannan, Kasthuri, primary, Luthra, Rajyalakshmi, primary, Alatrash, Gheath, primary, Huang, Hsin-Hui, primary, Xie, Hui, primary, Patel, Manishkumar, primary, Nie, Kai, primary, Harris, Jocelyn, primary, Argueta, Kimberly, primary, Lindsay, James, primary, Biswas, Roshni, primary, Van Nostrand, Stephen, primary, Kim-Schulze, Seunghee, primary, Gray, Jhanelle E., primary, Herbst, Roy S., primary, Wistuba, Ignacio I., primary, Gettinger, Scott, primary, Kelly, Karen, primary, Bazhenova, Lyudmila, primary, Gnjatic, Sacha, primary, Lee, J. Jack, primary, Zhang, Jianjun, primary, and Haymaker, Cara, primary

Published
2024
Full Text
View/download PDF

14. Supplementary Table 7 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, primary, Duose, Dzifa Yawa, primary, Gonzalez-Kozlova, Edgar, primary, Redman, Mary W., primary, Chen, Hong, primary, Manyam, Ganiraju C., primary, Kumar, Gayatri, primary, Zhang, Jianhua, primary, Song, Xingzhi, primary, Lazcano, Rossana, primary, Marques-Piubelli, Mario L., primary, Laberiano-Fernandez, Caddie, primary, Rojas, Frank, primary, Zhang, Baili, primary, Taing, Len, primary, Jhaveri, Aashna, primary, Geisberg, Jacob, primary, Altreuter, Jennifer, primary, Michor, Franziska, primary, Provencher, James, primary, Yu, Joyce, primary, Cerami, Ethan, primary, Moravec, Radim, primary, Kannan, Kasthuri, primary, Luthra, Rajyalakshmi, primary, Alatrash, Gheath, primary, Huang, Hsin-Hui, primary, Xie, Hui, primary, Patel, Manishkumar, primary, Nie, Kai, primary, Harris, Jocelyn, primary, Argueta, Kimberly, primary, Lindsay, James, primary, Biswas, Roshni, primary, Van Nostrand, Stephen, primary, Kim-Schulze, Seunghee, primary, Gray, Jhanelle E., primary, Herbst, Roy S., primary, Wistuba, Ignacio I., primary, Gettinger, Scott, primary, Kelly, Karen, primary, Bazhenova, Lyudmila, primary, Gnjatic, Sacha, primary, Lee, J. Jack, primary, Zhang, Jianjun, primary, and Haymaker, Cara, primary

Published
2024
Full Text
View/download PDF

15. Supplementary Table 4 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, primary, Duose, Dzifa Yawa, primary, Gonzalez-Kozlova, Edgar, primary, Redman, Mary W., primary, Chen, Hong, primary, Manyam, Ganiraju C., primary, Kumar, Gayatri, primary, Zhang, Jianhua, primary, Song, Xingzhi, primary, Lazcano, Rossana, primary, Marques-Piubelli, Mario L., primary, Laberiano-Fernandez, Caddie, primary, Rojas, Frank, primary, Zhang, Baili, primary, Taing, Len, primary, Jhaveri, Aashna, primary, Geisberg, Jacob, primary, Altreuter, Jennifer, primary, Michor, Franziska, primary, Provencher, James, primary, Yu, Joyce, primary, Cerami, Ethan, primary, Moravec, Radim, primary, Kannan, Kasthuri, primary, Luthra, Rajyalakshmi, primary, Alatrash, Gheath, primary, Huang, Hsin-Hui, primary, Xie, Hui, primary, Patel, Manishkumar, primary, Nie, Kai, primary, Harris, Jocelyn, primary, Argueta, Kimberly, primary, Lindsay, James, primary, Biswas, Roshni, primary, Van Nostrand, Stephen, primary, Kim-Schulze, Seunghee, primary, Gray, Jhanelle E., primary, Herbst, Roy S., primary, Wistuba, Ignacio I., primary, Gettinger, Scott, primary, Kelly, Karen, primary, Bazhenova, Lyudmila, primary, Gnjatic, Sacha, primary, Lee, J. Jack, primary, Zhang, Jianjun, primary, and Haymaker, Cara, primary

Published
2024
Full Text
View/download PDF

16. Supplementary Figure 5 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, primary, Duose, Dzifa Yawa, primary, Gonzalez-Kozlova, Edgar, primary, Redman, Mary W., primary, Chen, Hong, primary, Manyam, Ganiraju C., primary, Kumar, Gayatri, primary, Zhang, Jianhua, primary, Song, Xingzhi, primary, Lazcano, Rossana, primary, Marques-Piubelli, Mario L., primary, Laberiano-Fernandez, Caddie, primary, Rojas, Frank, primary, Zhang, Baili, primary, Taing, Len, primary, Jhaveri, Aashna, primary, Geisberg, Jacob, primary, Altreuter, Jennifer, primary, Michor, Franziska, primary, Provencher, James, primary, Yu, Joyce, primary, Cerami, Ethan, primary, Moravec, Radim, primary, Kannan, Kasthuri, primary, Luthra, Rajyalakshmi, primary, Alatrash, Gheath, primary, Huang, Hsin-Hui, primary, Xie, Hui, primary, Patel, Manishkumar, primary, Nie, Kai, primary, Harris, Jocelyn, primary, Argueta, Kimberly, primary, Lindsay, James, primary, Biswas, Roshni, primary, Van Nostrand, Stephen, primary, Kim-Schulze, Seunghee, primary, Gray, Jhanelle E., primary, Herbst, Roy S., primary, Wistuba, Ignacio I., primary, Gettinger, Scott, primary, Kelly, Karen, primary, Bazhenova, Lyudmila, primary, Gnjatic, Sacha, primary, Lee, J. Jack, primary, Zhang, Jianjun, primary, and Haymaker, Cara, primary

Published
2024
Full Text
View/download PDF

17. Supplementary Table 2 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, primary, Duose, Dzifa Yawa, primary, Gonzalez-Kozlova, Edgar, primary, Redman, Mary W., primary, Chen, Hong, primary, Manyam, Ganiraju C., primary, Kumar, Gayatri, primary, Zhang, Jianhua, primary, Song, Xingzhi, primary, Lazcano, Rossana, primary, Marques-Piubelli, Mario L., primary, Laberiano-Fernandez, Caddie, primary, Rojas, Frank, primary, Zhang, Baili, primary, Taing, Len, primary, Jhaveri, Aashna, primary, Geisberg, Jacob, primary, Altreuter, Jennifer, primary, Michor, Franziska, primary, Provencher, James, primary, Yu, Joyce, primary, Cerami, Ethan, primary, Moravec, Radim, primary, Kannan, Kasthuri, primary, Luthra, Rajyalakshmi, primary, Alatrash, Gheath, primary, Huang, Hsin-Hui, primary, Xie, Hui, primary, Patel, Manishkumar, primary, Nie, Kai, primary, Harris, Jocelyn, primary, Argueta, Kimberly, primary, Lindsay, James, primary, Biswas, Roshni, primary, Van Nostrand, Stephen, primary, Kim-Schulze, Seunghee, primary, Gray, Jhanelle E., primary, Herbst, Roy S., primary, Wistuba, Ignacio I., primary, Gettinger, Scott, primary, Kelly, Karen, primary, Bazhenova, Lyudmila, primary, Gnjatic, Sacha, primary, Lee, J. Jack, primary, Zhang, Jianjun, primary, and Haymaker, Cara, primary

Published
2024
Full Text
View/download PDF

18. Supplementary Figure 3 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, primary, Duose, Dzifa Yawa, primary, Gonzalez-Kozlova, Edgar, primary, Redman, Mary W., primary, Chen, Hong, primary, Manyam, Ganiraju C., primary, Kumar, Gayatri, primary, Zhang, Jianhua, primary, Song, Xingzhi, primary, Lazcano, Rossana, primary, Marques-Piubelli, Mario L., primary, Laberiano-Fernandez, Caddie, primary, Rojas, Frank, primary, Zhang, Baili, primary, Taing, Len, primary, Jhaveri, Aashna, primary, Geisberg, Jacob, primary, Altreuter, Jennifer, primary, Michor, Franziska, primary, Provencher, James, primary, Yu, Joyce, primary, Cerami, Ethan, primary, Moravec, Radim, primary, Kannan, Kasthuri, primary, Luthra, Rajyalakshmi, primary, Alatrash, Gheath, primary, Huang, Hsin-Hui, primary, Xie, Hui, primary, Patel, Manishkumar, primary, Nie, Kai, primary, Harris, Jocelyn, primary, Argueta, Kimberly, primary, Lindsay, James, primary, Biswas, Roshni, primary, Van Nostrand, Stephen, primary, Kim-Schulze, Seunghee, primary, Gray, Jhanelle E., primary, Herbst, Roy S., primary, Wistuba, Ignacio I., primary, Gettinger, Scott, primary, Kelly, Karen, primary, Bazhenova, Lyudmila, primary, Gnjatic, Sacha, primary, Lee, J. Jack, primary, Zhang, Jianjun, primary, and Haymaker, Cara, primary

Published
2024
Full Text
View/download PDF

19. Supplementary Figure 4 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, primary, Duose, Dzifa Yawa, primary, Gonzalez-Kozlova, Edgar, primary, Redman, Mary W., primary, Chen, Hong, primary, Manyam, Ganiraju C., primary, Kumar, Gayatri, primary, Zhang, Jianhua, primary, Song, Xingzhi, primary, Lazcano, Rossana, primary, Marques-Piubelli, Mario L., primary, Laberiano-Fernandez, Caddie, primary, Rojas, Frank, primary, Zhang, Baili, primary, Taing, Len, primary, Jhaveri, Aashna, primary, Geisberg, Jacob, primary, Altreuter, Jennifer, primary, Michor, Franziska, primary, Provencher, James, primary, Yu, Joyce, primary, Cerami, Ethan, primary, Moravec, Radim, primary, Kannan, Kasthuri, primary, Luthra, Rajyalakshmi, primary, Alatrash, Gheath, primary, Huang, Hsin-Hui, primary, Xie, Hui, primary, Patel, Manishkumar, primary, Nie, Kai, primary, Harris, Jocelyn, primary, Argueta, Kimberly, primary, Lindsay, James, primary, Biswas, Roshni, primary, Van Nostrand, Stephen, primary, Kim-Schulze, Seunghee, primary, Gray, Jhanelle E., primary, Herbst, Roy S., primary, Wistuba, Ignacio I., primary, Gettinger, Scott, primary, Kelly, Karen, primary, Bazhenova, Lyudmila, primary, Gnjatic, Sacha, primary, Lee, J. Jack, primary, Zhang, Jianjun, primary, and Haymaker, Cara, primary

Published
2024
Full Text
View/download PDF

20. Supplementary Table 5 from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, primary, Duose, Dzifa Yawa, primary, Gonzalez-Kozlova, Edgar, primary, Redman, Mary W., primary, Chen, Hong, primary, Manyam, Ganiraju C., primary, Kumar, Gayatri, primary, Zhang, Jianhua, primary, Song, Xingzhi, primary, Lazcano, Rossana, primary, Marques-Piubelli, Mario L., primary, Laberiano-Fernandez, Caddie, primary, Rojas, Frank, primary, Zhang, Baili, primary, Taing, Len, primary, Jhaveri, Aashna, primary, Geisberg, Jacob, primary, Altreuter, Jennifer, primary, Michor, Franziska, primary, Provencher, James, primary, Yu, Joyce, primary, Cerami, Ethan, primary, Moravec, Radim, primary, Kannan, Kasthuri, primary, Luthra, Rajyalakshmi, primary, Alatrash, Gheath, primary, Huang, Hsin-Hui, primary, Xie, Hui, primary, Patel, Manishkumar, primary, Nie, Kai, primary, Harris, Jocelyn, primary, Argueta, Kimberly, primary, Lindsay, James, primary, Biswas, Roshni, primary, Van Nostrand, Stephen, primary, Kim-Schulze, Seunghee, primary, Gray, Jhanelle E., primary, Herbst, Roy S., primary, Wistuba, Ignacio I., primary, Gettinger, Scott, primary, Kelly, Karen, primary, Bazhenova, Lyudmila, primary, Gnjatic, Sacha, primary, Lee, J. Jack, primary, Zhang, Jianjun, primary, and Haymaker, Cara, primary

Published
2024
Full Text
View/download PDF

22. Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Author

Parra, Edwin Roger, primary, Zhang, Jiexin, additional, Duose, Dzifa Yawa, additional, Gonzalez-Kozlova, Edgar, additional, Redman, Mary W., additional, Chen, Hong, additional, Manyam, Ganiraju C., additional, Kumar, Gayatri, additional, Zhang, Jianhua, additional, Song, Xingzhi, additional, Lazcano, Rossana, additional, Marques-Piubelli, Mario L., additional, Laberiano-Fernandez, Caddie, additional, Rojas, Frank, additional, Zhang, Baili, additional, Taing, Len, additional, Jhaveri, Aashna, additional, Geisberg, Jacob, additional, Altreuter, Jennifer, additional, Michor, Franziska, additional, Provencher, James, additional, Yu, Joyce, additional, Cerami, Ethan, additional, Moravec, Radim, additional, Kannan, Kasthuri, additional, Luthra, Rajyalakshmi, additional, Alatrash, Gheath, additional, Huang, Hsin-Hui, additional, Xie, Hui, additional, Patel, Manishkumar, additional, Nie, Kai, additional, Harris, Jocelyn, additional, Argueta, Kimberly, additional, Lindsay, James, additional, Biswas, Roshni, additional, Van Nostrand, Stephen, additional, Kim-Schulze, Seunghee, additional, Gray, Jhanelle E., additional, Herbst, Roy S., additional, Wistuba, Ignacio I., additional, Gettinger, Scott, additional, Kelly, Karen, additional, Bazhenova, Lyudmila, additional, Gnjatic, Sacha, additional, Lee, J. Jack, additional, Zhang, Jianjun, additional, and Haymaker, Cara, additional

Published
2024
Full Text
View/download PDF

23. PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program

Author

Li, Ling, Sun, Ruifang, Miao, Yi, Tran, Thai, Adams, Lisa, Roscoe, Nathan, Xu, Bing, Manyam, Ganiraju C., Tan, Xiaohong, Zhang, Hongwei, Xiao, Min, Tzankov, Alexandar, Visco, Carlo, Dybkaer, Karen, Bhagat, Govind, Tam, Wayne, Hsi, Eric D., van Krieken, J.Han, You, Hua, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Møller, Michael B., Piris, Miguel A., Zhang, Mingzhi, Winter, Jane N., Medeiros, L.Jeffrey, Rassidakis, George Z., Vaupel, Christine A., Li, Yong, Dakappagari, Naveen, Xu-Monette, Zijun Y., and Young, Ken H.

Published
2019
Full Text
View/download PDF

24. Supplementary Figure S7 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression

Author

Geng, Chuandong, primary, Zhang, Man-Chao, primary, Manyam, Ganiraju C., primary, Vykoukal, Jody V., primary, Fahrmann, Johannes F., primary, Peng, Shan, primary, Wu, Cheng, primary, Park, Sanghee, primary, Kondraganti, Shakuntala, primary, Wang, Daoqi, primary, Robinson, Brian D., primary, Loda, Massimo, primary, Barbieri, Christopher E., primary, Yap, Timothy A., primary, Corn, Paul G., primary, Hanash, Samir, primary, Broom, Bradley M., primary, Pilié, Patrick G., primary, and Thompson, Timothy C., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Table S11 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression

Author

Geng, Chuandong, primary, Zhang, Man-Chao, primary, Manyam, Ganiraju C., primary, Vykoukal, Jody V., primary, Fahrmann, Johannes F., primary, Peng, Shan, primary, Wu, Cheng, primary, Park, Sanghee, primary, Kondraganti, Shakuntala, primary, Wang, Daoqi, primary, Robinson, Brian D., primary, Loda, Massimo, primary, Barbieri, Christopher E., primary, Yap, Timothy A., primary, Corn, Paul G., primary, Hanash, Samir, primary, Broom, Bradley M., primary, Pilié, Patrick G., primary, and Thompson, Timothy C., primary

Published
2023
Full Text
View/download PDF

26. Supplementary Methods S1 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression

Author

Geng, Chuandong, primary, Zhang, Man-Chao, primary, Manyam, Ganiraju C., primary, Vykoukal, Jody V., primary, Fahrmann, Johannes F., primary, Peng, Shan, primary, Wu, Cheng, primary, Park, Sanghee, primary, Kondraganti, Shakuntala, primary, Wang, Daoqi, primary, Robinson, Brian D., primary, Loda, Massimo, primary, Barbieri, Christopher E., primary, Yap, Timothy A., primary, Corn, Paul G., primary, Hanash, Samir, primary, Broom, Bradley M., primary, Pilié, Patrick G., primary, and Thompson, Timothy C., primary

Published
2023
Full Text
View/download PDF

27. Data from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression

Author

Geng, Chuandong, primary, Zhang, Man-Chao, primary, Manyam, Ganiraju C., primary, Vykoukal, Jody V., primary, Fahrmann, Johannes F., primary, Peng, Shan, primary, Wu, Cheng, primary, Park, Sanghee, primary, Kondraganti, Shakuntala, primary, Wang, Daoqi, primary, Robinson, Brian D., primary, Loda, Massimo, primary, Barbieri, Christopher E., primary, Yap, Timothy A., primary, Corn, Paul G., primary, Hanash, Samir, primary, Broom, Bradley M., primary, Pilié, Patrick G., primary, and Thompson, Timothy C., primary

Published
2023
Full Text
View/download PDF

28. Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer

Author

Ding, Qingqing, Wang, Yan, Zuo, Zhuang, Gong, Yun, Krishnamurthy, Savitri, Li, Chia-Wei, Lai, Yun-Ju, Wei, Wei, Wang, Jing, Manyam, Ganiraju C., Diao, Lixia, Zhang, Xinna, Lin, Feng, Symmans, William F., Sun, Li, Liu, Chang-Gong, Liu, Xiuping, Debeb, Bisrat G., Ueno, Naoto T., Harano, Kenichi, Alvarez, Ricardo H., Wu, Yun, Cristofanilli, Massimo, and Huo, Lei

Published
2018
Full Text
View/download PDF

29. Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma

Author

Wang, Xiaoxiao, Cao, Xin, Sun, Ruifang, Tang, Charlene, Tzankov, Alexandar, Zhang, Jun, Manyam, Ganiraju C., Xiao, Min, Miao, Yi, Jabbar, Kausar, Tan, Xiaohong, Pang, Yuyang, Visco, Carlo, Xie, Yan, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Møller, Michael B., Parsons, Ben M., Winter, Jane N., Piris, Miguel A., Li, Shaoying, Miranda, Roberto N., Medeiros, L. Jeffrey, Li, Yong, Xu-Monette, Zijun Y., and Young, Ken H.

Published
2018
Full Text
View/download PDF

31. SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression

Author

Geng, Chuandong, primary, Zhang, Man-Chao, additional, Manyam, Ganiraju C., additional, Vykoukal, Jody V., additional, Fahrmann, Johannes F., additional, Peng, Shan, additional, Wu, Cheng, additional, Park, Sanghee, additional, Kondraganti, Shakuntala, additional, Wang, Daoqi, additional, Robinson, Brian D., additional, Loda, Massimo, additional, Barbieri, Christopher E., additional, Yap, Timothy A., additional, Corn, Paul G., additional, Hanash, Samir, additional, Broom, Bradley M., additional, Pilié, Patrick G., additional, and Thompson, Timothy C., additional

Published
2023
Full Text
View/download PDF

32. AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma

Author

Wang, Jinfen, Xu-Monette, Zijun Y., Jabbar, Kausar J., Shen, Qi, Manyam, Ganiraju C., Tzankov, Alexandar, Visco, Carlo, Wang, Jing, Montes-Moreno, Santiago, Dybkær, Karen, Tam, Wayne, Bhagat, Govind, Hsi, Eric D., van Krieken, J. Han, Ponzoni, Maurilio, Ferreri, Andrés J.M., Wang, Shi, Møller, Michael B., Piris, Miguel A., Medeiros, L. Jeffrey, Li, Yong, Pham, Lan V., and Young, Ken H.

Published
2017
Full Text
View/download PDF

35. The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate–resistant HER2-overexpressing breast cancer

Author

Lee, Jangsoon, primary, Kida, Kumiko, additional, Liu, Huey, additional, Manyam, Ganiraju C., additional, Gi, Young Jin, additional, Multani, Asha S., additional, Wang, Jing, additional, Jayachandran, Gitanjali, additional, Reuben, James M., additional, Huo, Lei, additional, Tripathy, Debu, additional, and Ueno, Naoto T., additional

Published
2023
Full Text
View/download PDF

36. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma

Author

Xu-Monette, Zijun Y., Li, Ling, Byrd, John C., Jabbar, Kausar J., Manyam, Ganiraju C., Maria de Winde, Charlotte, van den Brand, Michiel, Tzankov, Alexandar, Visco, Carlo, Wang, Jing, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Møller, Michael B., Parsons, Ben M., Winter, Jane N., Wang, Michael, Hagemeister, Frederick B., Piris, Miguel A., Han van Krieken, J., Medeiros, L.Jeffrey, Li, Yong, van Spriel, Annemiek B., and Young, Ken H.

Published
2016
Full Text
View/download PDF

37. Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies

Author

Xu-Monette, Zijun Y., Li, Jianyong, Xia, Yi, Crossley, Beryl, Bremel, Robert D., Miao, Yi, Xiao, Min, Snyder, Thomas, Manyam, Ganiraju C., Tan, Xiaohong, Zhang, Hongwei, Visco, Carlo, Tzankov, Alexandar, Dybkaer, Karen, Bhagat, Govind, Tam, Wayne, You, Hua, Hsi, Eric D., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J. M., Møller, Michael B., Piris, Miguel A., Winter, Jane N., Medeiros, Jeffrey T., Xu, Bing, Li, Yong, Kirsch, Ilan, and Young, Ken H.

Published
2019
Full Text
View/download PDF

39. Supplementary Tables from Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

Author

Xu-Monette, Ziju Y., primary, Xiao, Min, primary, Au, Qingyan, primary, Padmanabhan, Raghav, primary, Xu, Bing, primary, Hoe, Nicholas, primary, Rodríguez-Perales, Sandra, primary, Torres-Ruiz, Raul, primary, Manyam, Ganiraju C., primary, Visco, Carlo, primary, Miao, Yi, primary, Tan, Xiaohong, primary, Zhang, Hongwei, primary, Tzankov, Alexandar, primary, Wang, Jing, primary, Dybkær, Karen, primary, Tam, Wayne, primary, You, Hua, primary, Bhagat, Govind, primary, Hsi, Eric D., primary, Ponzoni, Maurilio, primary, Ferreri, Andrés J.M., primary, Møller, Michael B., primary, Piris, Miguel A., primary, van Krieken, J. Han, primary, Winter, Jane N., primary, Westin, Jason R., primary, Pham, Lan V., primary, Medeiros, L. Jeffrey, primary, Rassidakis, George Z., primary, Li, Yong, primary, Freeman, Gordon J., primary, and Young, Ken H., primary

Published
2023
Full Text
View/download PDF

40. Data from Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

Author

Xu-Monette, Ziju Y., primary, Xiao, Min, primary, Au, Qingyan, primary, Padmanabhan, Raghav, primary, Xu, Bing, primary, Hoe, Nicholas, primary, Rodríguez-Perales, Sandra, primary, Torres-Ruiz, Raul, primary, Manyam, Ganiraju C., primary, Visco, Carlo, primary, Miao, Yi, primary, Tan, Xiaohong, primary, Zhang, Hongwei, primary, Tzankov, Alexandar, primary, Wang, Jing, primary, Dybkær, Karen, primary, Tam, Wayne, primary, You, Hua, primary, Bhagat, Govind, primary, Hsi, Eric D., primary, Ponzoni, Maurilio, primary, Ferreri, Andrés J.M., primary, Møller, Michael B., primary, Piris, Miguel A., primary, van Krieken, J. Han, primary, Winter, Jane N., primary, Westin, Jason R., primary, Pham, Lan V., primary, Medeiros, L. Jeffrey, primary, Rassidakis, George Z., primary, Li, Yong, primary, Freeman, Gordon J., primary, and Young, Ken H., primary

Published
2023
Full Text
View/download PDF

41. Supplementary Figures 1-3 from Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

Author

Xu-Monette, Ziju Y., primary, Xiao, Min, primary, Au, Qingyan, primary, Padmanabhan, Raghav, primary, Xu, Bing, primary, Hoe, Nicholas, primary, Rodríguez-Perales, Sandra, primary, Torres-Ruiz, Raul, primary, Manyam, Ganiraju C., primary, Visco, Carlo, primary, Miao, Yi, primary, Tan, Xiaohong, primary, Zhang, Hongwei, primary, Tzankov, Alexandar, primary, Wang, Jing, primary, Dybkær, Karen, primary, Tam, Wayne, primary, You, Hua, primary, Bhagat, Govind, primary, Hsi, Eric D., primary, Ponzoni, Maurilio, primary, Ferreri, Andrés J.M., primary, Møller, Michael B., primary, Piris, Miguel A., primary, van Krieken, J. Han, primary, Winter, Jane N., primary, Westin, Jason R., primary, Pham, Lan V., primary, Medeiros, L. Jeffrey, primary, Rassidakis, George Z., primary, Li, Yong, primary, Freeman, Gordon J., primary, and Young, Ken H., primary

Published
2023
Full Text
View/download PDF

42. Supplmentary Documents including Methods, Tables, and Legends for Supplementary Figures, and Supplementary Figure S1-S5 from Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

Author

Xu-Monette, Zijun Y., primary, Deng, Qipan, primary, Manyam, Ganiraju C., primary, Tzankov, Alexander, primary, Li, Ling, primary, Xia, Yi, primary, Wang, Xiao-xiao, primary, Zou, Dehui, primary, Visco, Carlo, primary, Dybkær, Karen, primary, Li, Jun, primary, Zhang, Li, primary, Liang, Han, primary, Montes-Moreno, Santiago, primary, Chiu, April, primary, Orazi, Attilio, primary, Zu, Youli, primary, Bhagat, Govind, primary, Richards, Kristy L., primary, Hsi, Eric D., primary, Choi, William W.L., primary, van Krieken, J. Han, primary, Huh, Jooryung, primary, Ponzoni, Maurilio, primary, Ferreri, Andrés J.M., primary, Parsons, Ben M., primary, Møller, Michael B., primary, Wang, Sa A., primary, Miranda, Roberto N., primary, Piris, Miguel A., primary, Winter, Jane N., primary, Medeiros, L. Jeffrey, primary, Li, Yong, primary, and Young, Ken H., primary

Published
2023
Full Text
View/download PDF

43. Supplementary Table 1 from Prevalence and Clinical Implications of Epstein–Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries

Author

Ok, Chi Young, primary, Li, Ling, primary, Xu-Monette, Zijun Y., primary, Visco, Carlo, primary, Tzankov, Alexander, primary, Manyam, Ganiraju C., primary, Montes-Moreno, Santiago, primary, Dybaer, Karen, primary, Chiu, April, primary, Orazi, Attilio, primary, Zu, Youli, primary, Bhagat, Govind, primary, Chen, Jiayu, primary, Richards, Kristy L., primary, Hsi, Eric D., primary, Choi, William W. L., primary, van Krieken, J. Han, primary, Huh, Jooryung, primary, Ai, Weiyun, primary, Ponzoni, Maurilio, primary, Ferreri, Andrés J.M., primary, Farnen, John P., primary, Møller, Michael B., primary, Bueso-Ramos, Carlo E., primary, Miranda, Roberto N., primary, Winter, Jane N., primary, Piris, Miguel A., primary, Medeiros, L. Jeffrey, primary, and Young, Ken H., primary

Published
2023
Full Text
View/download PDF

44. Table S2 from The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development

Author

Palanisamy, Nallasivam, primary, Yang, Jun, primary, Shepherd, Peter D.A., primary, Li-Ning-Tapia, Elsa M., primary, Labanca, Estefania, primary, Manyam, Ganiraju C., primary, Ravoori, Murali K., primary, Kundra, Vikas, primary, Araujo, John C., primary, Efstathiou, Eleni, primary, Pisters, Louis L., primary, Wan, Xinhai, primary, Wang, Xuemei, primary, Vazquez, Elba S., primary, Aparicio, Ana M., primary, Carskadon, Shannon L., primary, Tomlins, Scott A., primary, Kunju, Lakshmi P., primary, Chinnaiyan, Arul M., primary, Broom, Bradley M., primary, Logothetis, Christopher J., primary, Troncoso, Patricia, primary, and Navone, Nora M., primary

Published
2023
Full Text
View/download PDF

45. Legend of Supplementary Figures from The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development

Author

Palanisamy, Nallasivam, primary, Yang, Jun, primary, Shepherd, Peter D.A., primary, Li-Ning-Tapia, Elsa M., primary, Labanca, Estefania, primary, Manyam, Ganiraju C., primary, Ravoori, Murali K., primary, Kundra, Vikas, primary, Araujo, John C., primary, Efstathiou, Eleni, primary, Pisters, Louis L., primary, Wan, Xinhai, primary, Wang, Xuemei, primary, Vazquez, Elba S., primary, Aparicio, Ana M., primary, Carskadon, Shannon L., primary, Tomlins, Scott A., primary, Kunju, Lakshmi P., primary, Chinnaiyan, Arul M., primary, Broom, Bradley M., primary, Logothetis, Christopher J., primary, Troncoso, Patricia, primary, and Navone, Nora M., primary

Published
2023
Full Text
View/download PDF

46. Figure S7 from The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development

Author

Palanisamy, Nallasivam, primary, Yang, Jun, primary, Shepherd, Peter D.A., primary, Li-Ning-Tapia, Elsa M., primary, Labanca, Estefania, primary, Manyam, Ganiraju C., primary, Ravoori, Murali K., primary, Kundra, Vikas, primary, Araujo, John C., primary, Efstathiou, Eleni, primary, Pisters, Louis L., primary, Wan, Xinhai, primary, Wang, Xuemei, primary, Vazquez, Elba S., primary, Aparicio, Ana M., primary, Carskadon, Shannon L., primary, Tomlins, Scott A., primary, Kunju, Lakshmi P., primary, Chinnaiyan, Arul M., primary, Broom, Bradley M., primary, Logothetis, Christopher J., primary, Troncoso, Patricia, primary, and Navone, Nora M., primary

Published
2023
Full Text
View/download PDF

47. Supplementary Methods from The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development

Author

Palanisamy, Nallasivam, primary, Yang, Jun, primary, Shepherd, Peter D.A., primary, Li-Ning-Tapia, Elsa M., primary, Labanca, Estefania, primary, Manyam, Ganiraju C., primary, Ravoori, Murali K., primary, Kundra, Vikas, primary, Araujo, John C., primary, Efstathiou, Eleni, primary, Pisters, Louis L., primary, Wan, Xinhai, primary, Wang, Xuemei, primary, Vazquez, Elba S., primary, Aparicio, Ana M., primary, Carskadon, Shannon L., primary, Tomlins, Scott A., primary, Kunju, Lakshmi P., primary, Chinnaiyan, Arul M., primary, Broom, Bradley M., primary, Logothetis, Christopher J., primary, Troncoso, Patricia, primary, and Navone, Nora M., primary

Published
2023
Full Text
View/download PDF

48. Table S1 from ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer

Author

Mehrvarz Sarshekeh, Amir, primary, Alshenaifi, Jumanah, primary, Roszik, Jason, primary, Manyam, Ganiraju C., primary, Advani, Shailesh M., primary, Katkhuda, Riham, primary, Verma, Anuj, primary, Lam, Michael, primary, Willis, Jason, primary, Shen, John Paul, primary, Morris, Jeffrey, primary, Davis, Jennifer S., primary, Loree, Jonathan M., primary, Lee, Hey Min, primary, Ajani, Jaffer A., primary, Maru, Dipen M., primary, Overman, Michael J., primary, and Kopetz, Scott, primary

Published
2023
Full Text
View/download PDF

49. Supplementary Results from The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development

Author

Palanisamy, Nallasivam, primary, Yang, Jun, primary, Shepherd, Peter D.A., primary, Li-Ning-Tapia, Elsa M., primary, Labanca, Estefania, primary, Manyam, Ganiraju C., primary, Ravoori, Murali K., primary, Kundra, Vikas, primary, Araujo, John C., primary, Efstathiou, Eleni, primary, Pisters, Louis L., primary, Wan, Xinhai, primary, Wang, Xuemei, primary, Vazquez, Elba S., primary, Aparicio, Ana M., primary, Carskadon, Shannon L., primary, Tomlins, Scott A., primary, Kunju, Lakshmi P., primary, Chinnaiyan, Arul M., primary, Broom, Bradley M., primary, Logothetis, Christopher J., primary, Troncoso, Patricia, primary, and Navone, Nora M., primary

Published
2023
Full Text
View/download PDF

50. Figure S3 from ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer

Author

Mehrvarz Sarshekeh, Amir, primary, Alshenaifi, Jumanah, primary, Roszik, Jason, primary, Manyam, Ganiraju C., primary, Advani, Shailesh M., primary, Katkhuda, Riham, primary, Verma, Anuj, primary, Lam, Michael, primary, Willis, Jason, primary, Shen, John Paul, primary, Morris, Jeffrey, primary, Davis, Jennifer S., primary, Loree, Jonathan M., primary, Lee, Hey Min, primary, Ajani, Jaffer A., primary, Maru, Dipen M., primary, Overman, Michael J., primary, and Kopetz, Scott, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results